JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

Buprenorphine's Dose Response Curve

Phase 2

Completed

Conditions: Opioid-related Disorders

Interventions: Drug: Buprenorphine
Drug: Morphine
Drug: Placebo

First Posted Date: 2007-04-13

Last Posted Date: 2017-03-03

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 12

Registration Number: NCT00460239

Locations: 🇺🇸
Johns Hopkins University (BPRU) Bayview Campus, Baltimore, Maryland, United States

Peer Support for Increasing Physical Activity in People With Serious Mental Illnesses

Not Applicable

Completed

Conditions: Depression
Bipolar Disorder
Personality Disorders
Anxiety Disorders
Cognitive Disorders
Schizophrenia

Interventions: Behavioral: Physical activity intervention without peer support (PA)
Behavioral: Physical activity intervention with peer support (PA+PS)

First Posted Date: 2007-04-09

Last Posted Date: 2017-12-06

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 100

Registration Number: NCT00458094

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Telephone Intervention to Increase Safety in Abused Women

Not Applicable

Completed

Conditions: Intimate Partner Violence

First Posted Date: 2007-04-06

Last Posted Date: 2018-01-18

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 40

Registration Number: NCT00457522

Locations: 🇺🇸
The Shepherd's Clinic, Baltimore, Maryland, United States

Improving Outcomes Following Limb Loss: PALS Plus

Phase 1

Completed

Conditions: Amputation

First Posted Date: 2007-03-15

Last Posted Date: 2017-12-13

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 400

Registration Number: NCT00447655

Locations: 🇺🇸
Good Samaritan Hospital, Baltimore, Maryland, United States

Community-Based Violence Prevention for High-Risk Youth

Phase 2

Completed

Conditions: Fighting Behavior
Aggression

First Posted Date: 2007-03-07

Last Posted Date: 2007-03-07

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 198

Registration Number: NCT00444197

Locations: 🇺🇸
Children's National Medical Center, Washington, District of Columbia, United States
🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Lansoprazole to Treat Children With Asthma

Phase 4

Completed

Conditions: Asthma

Interventions: Drug: Matching placebo
Drug: Lansoprazole

First Posted Date: 2007-03-01

Last Posted Date: 2012-12-06

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 306

Registration Number: NCT00442013

Locations: 🇺🇸
University of Miami School of Medicine, Miami, Florida, United States
🇺🇸
Indiana University, Indianapolis, Indiana, United States
🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

and more 17 locations

Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-operative Cystoid Macular Edema.

Phase 2

Withdrawn

Conditions: Cystoid Macular Edema

Interventions: Drug: Refresh Plus
Drug: Bromfenac (Xibrom)

First Posted Date: 2007-02-22

Last Posted Date: 2016-07-04

Lead Sponsor: Johns Hopkins University

Registration Number: NCT00438243

Locations: 🇺🇸
The Johns Hopkins Hospital, Baltimore, Maryland, United States

Cancer of the Pancreas Screening Study (CAPS 3)

Completed

Conditions: Peutz-Jeghers Syndrome
Pancreatic Neoplasm

First Posted Date: 2007-02-22

Last Posted Date: 2021-06-18

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 200

Registration Number: NCT00438906

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Internet Administration of the Modified Atkins Diet for Adults With Intractable Epilepsy

Phase 3

Completed

Conditions: Epilepsy

Interventions: Behavioral: Dietary management of seizures

First Posted Date: 2007-02-19

Last Posted Date: 2015-09-02

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 30

Registration Number: NCT00436631

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus

Active, not recruiting

Conditions: Barrett Esophagus
Esophageal Neoplasm
Gastroesophageal Reflux

First Posted Date: 2007-02-06

Last Posted Date: 2024-05-13

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 600

Registration Number: NCT00431756

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy